Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...

Lilly said patients must refill their prescriptions of the two higher-dose vials within 45 days of their first fill to get the same pricing, and would otherwise have to pay as much as $699 for ...

Shares of the Indianapolis-based drugmaker rose 2.3% to $902.42. The launch of Lilly's vials expands options for patients who choose to pay cash through the drugmaker's direct-to-consumer website ...

Lilly Offers Weight-Loss Drugs in Vials at a Discount to Fight Competition By Patrick Wingrove and Sriparna Roy (Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss ...

Ampicillin/sulbactam 3 g iv. q 6 h for 48 h iv. vial: (2 g:1 g) for 48 h US$80 ‡ Ceftriaxone 1 g iv. q 12 h for 48 h iv. vial: (250 mg) US$3; iv. vial: (2 g) for 48 h US$18.28 ‡ Cefixime 400 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Edited by Joseph Kieber, The University of North Carolina at Chapel Hill, Chapel Hill, NC; received November 27, 2024; accepted January 7, 2025 ...